Phase I – Other

1,082 trials 243 recruiting

Filter these 1,082 trials by condition, country, sponsor and more.

Open in Search →

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis Ended

2023-505127-31-00 Rheumatoid Arthritis 2024-02-08
A trial to learn how baxdrostat affects the heartbeat in healthy participants Ended

2023-506108-23-00 Treatment-resistant hypertension 2024-02-06
Feasibility and tolerability of 28 days intravaginal oxybutynin via the MedRing OAB system Ended

2023-508692-36-00 Overactive bladder 2024-02-06
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam Ended

2023-508518-40-00 ER+/HER2 positive breast cancer 2024-02-05
Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis Ended

2022-502997-18-00 Atopic Dermatitis 2024-02-02
Randomised, crossover bioavailability clinical trial of oral minoxidil 1 mg, after single and multiple dose administration to healthy volunt… Ended

2023-503796-14-00 Androgenetic alopecia 2024-02-01
Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants Ended

2023-504460-41-00 Fibrostenotic Crohn’s disease 2024-01-30
A Study to Learn How Different Manufactured Products of the Study Medicine Called Ritlecitinib are Taken up Into the Blood in Healthy Adults… Ended

2023-505603-23-00 ulcerative colitis, Crohn’s Disease, alopecia areata, r 2024-01-29
Effect of cannabidiol on muscle recovery following a single bout of resistance exercise. Ended

2024-513768-24-00 Healthy individuals 2024-01-29
An open-label cocktail drug-drug interaction (DDI) clinical study to assess the effect of multiple oral dosing with leniolisib on the pharma… Ended

2023-507134-25-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 2024-01-29
ADME: A Study to Understand What the Body does to the Study Compound Called PF-07220060 When Taken by Healthy Adults. Ended

2023-507074-40-00 metastatic/advanced breast cancer 2024-01-26
An open-label, single-dose, parallel-group study to evaluate the plasma pharmacokinetics of leniolisib in subjects with impaired hepatic fun… Ended

2023-508519-22-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 2024-01-26
A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended

2023-504693-38-00 Healthy 2024-01-25
Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects Ended

2023-507997-41-00 Chronic cough 2024-01-25
A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants Ended

2022-502771-38-00 Advanced non-small cell lung cancer with EGFR and/or HE 2024-01-24
Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN Ended

2023-505796-76-00 Locally Advanced Squamous Cell Carcinoma of the Head an 2024-01-18
Phase 0 lead-in trial of Pitavastatin in primary and recurrent Glioblastoma patients Ended

2023-505743-38-00 Glioblastoma Multiforme 2024-01-18
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685… Ended

2023-506367-33-00 Healthy volunteer trial 2024-01-16
A randomized, Phase 1b, single-center, observer-blind, active-controlled study to evaluate the safety, immunogenicity, and immunological mec… Ended

2023-508230-33-00 Influenza 2024-01-12
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment Ended

2023-503919-15-00 Prostatic Neoplasms 2024-01-09
A phase 1, randomised, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to evaluate the safety, tol… Ended

2023-506912-41-00 Idiopathic pulmonary fibrosis 2024-01-09
A study to evaluate how the body absorbs, breaks down and removes drug as well as safety and tolerability when two drugs are administered to… Ended

2023-506580-34-00 Healthy Volunteers 2024-01-04
A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when gi… Ended

2023-503415-15-00 Tenosynovial Giant Cell Tumor (TGCT) 2023-12-21
A Sub Study to Learn About the Study Medication Called Etrasimod Tablets in a Hybrid Decentralized Clinical Trial Setting Ended

2023-508119-22-00 immune-mediated inflammatory disorders, including ulcer 2023-12-18